WallStSmart

Diebold Nixdorf, Incorporated (DBD)vsNVIDIA Corporation (NVDA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

NVIDIA Corporation generates 6473% more annual revenue ($253.49B vs $3.86B). DBD leads profitability with a 2.8% profit margin vs 0.6%. DBD trades at a lower P/E of 28.0x. NVDA earns a higher WallStSmart Score of 80/100 (A-).

DBD

Buy

56

out of 100

Grade: C

Growth: 7.0Profit: 5.5Value: 5.3Quality: 5.0

NVDA

Exceptional Buy

80

out of 100

Grade: A-

Growth: 6.0Profit: 5.5Value: 4.7Quality: 8.5
Piotroski: 3/9Altman Z: 6.75
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for DBD.

NVDASignificantly Overvalued (-78.2%)

Margin of Safety

-78.2%

Fair Value

$119.30

Current Price

$211.14

$91.84 premium

UndervaluedFair: $119.30Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DBD2 strengths · Avg: 9.0/10
EPS GrowthGrowth
815.0%10/10

Earnings expanding 815.0% YoY

Price/BookValuation
2.8x8/10

Reasonable price relative to book value

NVDA6 strengths · Avg: 9.7/10
Market CapQuality
$5.22T10/10

Mega-cap, among the largest globally

Return on EquityProfitability
81.7%10/10

Every $100 of equity generates 82 in profit

Debt/EquityHealth
0.0710/10

Conservative balance sheet, low leverage

Free Cash FlowQuality
$48.59B10/10

Generating 48.6B in free cash flow

Altman Z-ScoreHealth
6.7510/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.668/10

Growing faster than its price suggests

Areas to Watch

DBD2 concerns · Avg: 3.5/10
P/E RatioValuation
28.0x4/10

Moderate valuation

Profit MarginProfitability
2.8%3/10

2.8% margin — thin

NVDA4 concerns · Avg: 3.8/10
P/E RatioValuation
33.0x4/10

Premium valuation, high expectations priced in

Revenue GrowthGrowth
0.9%4/10

0.9% revenue growth

EPS GrowthGrowth
2.1%4/10

2.1% earnings growth

Profit MarginProfitability
0.6%3/10

0.6% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : DBD

The strongest argument for DBD centers on EPS Growth, Price/Book.

Bull Case : NVDA

The strongest argument for NVDA centers on Market Cap, Return on Equity, Debt/Equity. PEG of 0.66 suggests the stock is reasonably priced for its growth.

Bear Case : DBD

The primary concerns for DBD are P/E Ratio, Profit Margin. Thin 2.8% margins leave little buffer for downturns.

Bear Case : NVDA

The primary concerns for NVDA are P/E Ratio, Revenue Growth, EPS Growth. Thin 0.6% margins leave little buffer for downturns.

Key Dynamics to Monitor

NVDA carries more volatility with a beta of 2.24 — expect wider price swings.

DBD is growing revenue faster at 6.0% — sustainability is the question.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NVDA scores higher overall (80/100 vs 56/100). Both earn "Exceptional Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Diebold Nixdorf, Incorporated

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Diebold Nixdorf, Incorporated provides connected commerce solutions to financial institutions and retailers in Western Europe, Eastern Europe, Asia, the Middle East, Africa, the United States, Canada, Mexico and Latin America. The company is headquartered in North Canton, Ohio.

NVIDIA Corporation

TECHNOLOGY · SEMICONDUCTORS · USA

Nvidia Corporation is an American multinational technology company incorporated in Delaware and based in Santa Clara, California. It designs graphics processing units (GPUs) for the gaming and professional markets, as well as system on a chip units (SoCs) for the mobile computing and automotive market.

Visit Website →

Want to dig deeper into these stocks?